Search

You searched for "intravitreal"

557 results found
Strabismus journal front cover image.

Complications of limbal stay sutures

3 October 2022 | | EYE - Paediatrics, EYE - Strabismus
There is limited literature describing complications at the limbal suture site. The authors describe two cases with postoperative complications due to use of intraoperative limbal stay sutures. Each case had strabismus surgery at other centres but with presentation to the...

Corneal Tissue Addition Keratoplasty

5 June 2026 | Company Profiles, Research & Development
Corza Medical has launched a dedicated CTAK (Corneal Tissue Addition Keratoplasty) instrument set, developed in partnership with CorneaGen, to support surgeons performing this approach to keratoconus treatment. CTAK is an intrastromal lamellar keratoplasty procedure using preserved donor corneal tissue, custom...

The management of retinal vein occlusions: a summary

1 February 2015 | | EYE - Cataract, EYE - Refractive, EYE - Cornea, EYE - Imaging, EYE - Vitreo-Retinal, EYE - General
Retinal vein occlusions (RVO) are the most common cause of visual loss from retinal vascular disease second to diabetic retinopathy. Vision is lost due to ischaemia, macular oedema and / or haemorrhage which ultimately effects a patient’s quality of life...

My top five: Emerging alternatives to manage and treat nAMD

3 April 2024 | | EYE - Vitreo-Retinal
Wet (exudative or neovascular) age-related macular degeneration (AMD) is characterised by choroidal neovascularisation, in which new blood vessels from the choroid invade through Bruch’s membrane. These blood vessels proliferate beneath or through the retinal pigment epithelium (RPE), causing patients to...

My Top Five: Emerging alternatives to manage and treat nAMD

3 April 2024 | | EYE - General
Wet (exudative or neovascular) age-related macular degeneration (AMD) is characterised by choroidal neovascularisation, in which new blood vessels from the choroid invade through Bruch’s membrane. These blood vessels proliferate beneath or through the retinal pigment epithelium (RPE), causing patients to...

Emerging therapies for geographic atrophy: complement inhibitors show potential to slow progression and preserve RPE and photoreceptor integrity

5 June 2023 |
Geographic atrophy (GA) is an advanced form of age-related macular degeneration (AMD) characterised by progressive, irreversible loss of the retinal pigment epithelium (RPE) and photoreceptors and is estimated to account for approximately 10% of AMD-related blindness [1-4]. The Age-Related Eye...

Is patient masking leading to an increase in post-op infection after eyelid surgery?

21 October 2020 | | EYE - Oculoplastic
Due to the COVID-19 pandemic, the use of facemasks or face coverings in the clinical setting has become necessary. It is important to recognise that facemasks can be a source of infection after eye surgery and consider ways to minimise...

My Top Five: Promising gene therapies for ocular conditions

4 December 2024 | | EYE - Vitreo-Retinal
Gene therapy, a pivotal advancement in modern medicine, particularly shines in ophthalmology. By targeting defective genes with engineered vectors, this approach promises significant strides in treating inherited retinal diseases. This article reviews the top five gene therapies in late-stage trials,...

My Top Five: Promising gene therapies for ocular conditions

4 December 2024 | | EYE - Vitreo-Retinal
Gene therapy, a pivotal advancement in modern medicine, particularly shines in ophthalmology. By targeting defective genes with engineered vectors, this approach promises significant strides in treating inherited retinal diseases. This article reviews the top five gene therapies in late-stage trials,...

A rare case of endogenous panophthalmitis: Nidus from an E. coli urinary tract infection

3 June 2026 | | EYE - Imaging, EYE - Orbit, EYE - Pathology
Endogenous bacterial endophthalmitis (EBE) is a form of severe inflammation caused by haematogenous spread of a virulent bacterium from a nidus elsewhere in the body to intraocular tissues. It is a rare occurrence and only constitutes around 2–8% of all...

The National Treatment Centre-Highland

8 September 2023 | National Treatment Centre-Highland, Andy Pyott, Scotland, Eyecare, Raigmore, NHS Highland
The National Treatment Centre-Highland opened its doors to patients in April 2023. At a cost of £48 million this represented a significant investment by the Scottish Government for the provision of modern eye care for the North of Scotland.

Introducing BEAMS: A new national society for medical retina specialists

26 September 2025 | meetings, conference, society, retina, medical retina
The specialty of medical retina is evolving. Initially, limited to pattern recognition and in later times, laser treatment, the past 20 years has seen an explosion of intravitreal therapies and a very rich pipeline resulting in sight-saving outcomes and hope...